Published in World J Stem Cells on August 26, 2015
Gene targeting of the transcription factor Mohawk in rats causes heterotopic ossification of Achilles tendon via failed tenogenesis. Proc Natl Acad Sci U S A (2016) 0.83
Transgenic rat models for mutagenesis and carcinogenesis. Genes Environ (2017) 0.75
Gene Targeting Using Homologous Recombination in Embryonic Stem Cells: The Future for Behavior Genetics? Front Genet (2016) 0.75
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
The ground state of embryonic stem cell self-renewal. Nature (2008) 19.44
A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol (2007) 13.56
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 13.47
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2003) 12.94
Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33
GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci (2003) 10.89
Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45
The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci (2004) 7.92
Capture of authentic embryonic stem cells from rat blastocysts. Cell (2008) 6.60
Derivation of novel human ground state naive pluripotent stem cells. Nature (2013) 5.90
Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.84
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development (2007) 5.62
Germline competent embryonic stem cells derived from rat blastocysts. Cell (2008) 5.52
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol (2000) 4.80
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell (2008) 4.63
Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19
Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res (2002) 3.52
Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol (2011) 3.25
Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One (2010) 3.09
Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell (2012) 3.03
Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature (2010) 2.92
GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci (2009) 2.87
Laboratory animals: the Renaissance rat. Nature (2004) 2.84
High-frequency developmental abnormalities in p53-deficient mice. Curr Biol (1995) 2.57
Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet (2002) 2.44
Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation. Nat Cell Biol (2011) 2.32
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
The embryonic development of mammalian neural tube defects. Prog Neurobiol (1990) 1.99
Human embryonic stem cells. J Cell Sci (2000) 1.87
Genetic regulation of stem cell origins in the mouse embryo. Clin Genet (2005) 1.76
Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors. J Neurosci Res (2008) 1.70
Transgenic rat model of Huntington's disease. Hum Mol Genet (2003) 1.66
Characterization of immunoglobulin heavy chain knockout rats. Eur J Immunol (2010) 1.63
Generation of genetically modified rats from embryonic stem cells. Proc Natl Acad Sci U S A (2010) 1.59
Whole-rat conditional gene knockout via genome editing. Nat Methods (2013) 1.53
Generating gene knockout rats by homologous recombination in embryonic stem cells. Nat Protoc (2011) 1.32
Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition. Stem Cell Reports (2013) 1.31
Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev Neurobiol (2008) 1.27
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. J Neurosci (2013) 1.17
Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth. Exp Cell Res (2000) 1.14
In vitro models for liver toxicity testing. Toxicol Res (Camb) (2012) 1.13
Mechanisms of trophectoderm fate specification in preimplantation mouse development. Dev Growth Differ (2010) 1.11
Creation and characterization of a renin knockout rat. Hypertension (2011) 1.09
Generation of germline-competent rat induced pluripotent stem cells. PLoS One (2011) 1.08
Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency. Mol Reprod Dev (2010) 1.07
Efficient gene targeting by homologous recombination in rat embryonic stem cells. PLoS One (2010) 1.01
Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J (2012) 1.00
Derivation of a germline competent transgenic Fischer 344 embryonic stem cell line. PLoS One (2013) 0.99
Generating conditional knockout mice. Methods Mol Biol (2011) 0.97
Beyond knockout rats: new insights into finer genome manipulation in rats. Cell Cycle (2011) 0.96
Rat transgenesis via embryonic stem cells electroporated with the Kusabira-orange gene. Mol Reprod Dev (2010) 0.96
Derivation and characterization of embryonic stem cells lines derived from transgenic Fischer 344 and Dark Agouti rats. Stem Cells Dev (2011) 0.96
Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol (2012) 0.94
Derivation of rat embryonic stem cells and generation of protease-activated receptor-2 knockout rats. Transgenic Res (2011) 0.94
Pluripotent stem cells and other technologies will eventually open the door for straightforward gene targeting in the rat. Dis Model Mech (2009) 0.94
Germline transmission of a novel rat embryonic stem cell line derived from transgenic rats. Stem Cells Dev (2012) 0.93
Creation and preliminary characterization of a leptin knockout rat. Endocrinology (2012) 0.90
In vitro differentiation of rat embryonic stem cells into functional cardiomyocytes. Cell Res (2011) 0.89
Addition of serum to electroporated cells enhances survival and transfection efficiency. Biochem Biophys Res Commun (1990) 0.88
Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behav Neurosci (2014) 0.88
Characterization of multidrug resistance 1a/P-glycoprotein knockout rats generated by zinc finger nucleases. Mol Pharmacol (2011) 0.88
Molecular cloning and functional analysis of cDNA encoding a rat leukemia inhibitory factor: towards generation of pluripotent rat embryonic stem cells. Oncogene (1998) 0.87
Culture parameters for stable expansion, genetic modification and germline transmission of rat pluripotent stem cells. Biol Open (2011) 0.87
Two distinct knockout approaches highlight a critical role for p53 in rat development. Sci Rep (2012) 0.84
A focused microarray for screening rat embryonic stem cell lines. Stem Cells Dev (2012) 0.83
Toll-like receptor 4 (Tlr4) knockout rats produced by transcriptional activator-like effector nuclease (TALEN)-mediated gene inactivation. Alcohol (2013) 0.81
Derivation of germline competent rat embryonic stem cells from DA rats. J Genet Genomics (2012) 0.78
Conversion of rat embryonic stem cells into neural precursors in chemical-defined medium. Biochem Biophys Res Commun (2013) 0.77
In vitro methodologies for enhanced toxicity testing. Toxicol Lett (1993) 0.76